Biodesix, Inc.
Clinical trials sponsored by Biodesix, Inc., explained in plain language.
-
Blood test aims to reduce unnecessary lung procedures
Diagnosis OngoingThis study is testing whether a new blood test called Nodify XL2 helps doctors better manage lung nodules found on CT scans. It involves 2000 adults with solid lung nodules that have a low to moderate chance of being cancer. The goal is to see if using the test results leads to f…
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated Apr 04, 2026 01:51 UTC
-
Massive study tracks how blood test influences lung cancer care
Knowledge-focused OngoingThis study is observing how doctors use a blood test called VeriStrat to help decide on treatments for patients with a common type of lung cancer. It involves over 5,000 patients and aims to see if the test results help predict which treatments work better for different people. T…
Sponsor: Biodesix, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC